Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49.

The European journal of health economics : HEPAC : health economics in prevention and care - 1 Jun 2007

Norman Richard P A, Evans D Gareth, Easton Douglas F, Young Kenneth C

Abstract excerpt

Recent evidence has investigated the cost-effectiveness of magnetic resonance imaging (MRI) in younger women with a BRCA1 mutation. However, this evidence has not been contrasted with existing cost-effectiveness standards to determine whether screening is appropriate, given limited societal resources. We constructed a Markov model investigating surveillance tools (mammography, MRI, both in parallel) under a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA1 gene

Share to NHS gene

Share to Genes, BRCA1

Share to Magnetic Resonance Imaging

Share to Markov Chains

Share to Mutation

Source

Identifiers

PMID: 17347845
DOI: 10.1007/s10198-007-0042-9

Genes

BRCA1
NHS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49.PMID 17347845Read ↗

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.Semantic proximity Read ↗

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.Semantic proximity Read ↗

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.Semantic proximity Read ↗

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.Semantic proximity Read ↗

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.Semantic proximity Read ↗

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.Semantic proximity Read ↗

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.Semantic proximity Read ↗

Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.Semantic proximity Read ↗

Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.Semantic proximity Read ↗

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis.Semantic proximity Read ↗

Beyond the AJR: "Cost-Effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk".Semantic proximity Read ↗

Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.